華邦科技(03638.HK):陸建明辭任主席兼行政總裁等職
格隆匯5月6日丨華邦科技(03638.HK)公吿,陸建明已於2022年5月6日辭任公司執行董事、主席兼行政總裁,以投入更多時間專注其其他事業發展。
董事會亦宣佈,自2022年5月6日起,(1)陸建明不再擔任公司薪酬委員會、提名委員會及企業管治委員會成員;(2)執行董事及董事會副主席劉喬松已獲委任為公司薪酬委員會、提名委員會及企業管治委員會成員及企業管治委員會主席;及(3)公司執行董事瞿洪清已獲委任為公司企業管治委員會成員及黃國明不再為公司企業管治委員會主席及成員。
董事會將在切實可行情況下儘快提名合適人選擔任董事會主席,並將適時作出必要公佈。劉喬松將暫時履行主席職責,直至選出新任主席止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.